These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24977105)

  • 21. Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy?
    Shima H; Yamada A; Ishikawa T; Endo I
    Gland Surg; 2017 Feb; 6(1):82-88. PubMed ID: 28210556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147
    Lv Y; Wang T; Fan J; Zhang Z; Zhang J; Xu C; Li Y; Zhao G; He C; Meng H; Yang H; Wang Z; Liu J; Chen J; Wang L
    Tumour Biol; 2017 Apr; 39(4):1010428317695927. PubMed ID: 28381172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting.
    Lv L; Shi Y; Wu J; Li G
    Int J Nanomedicine; 2021; 16():1487-1508. PubMed ID: 33654398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autophagy as a Therapeutic Target in Breast Tumors: The Cancer stem cell perspective.
    Raza S; Siddiqui JA; Srivastava A; Chattopadhyay N; Sinha RA; Chakravarti B
    Autophagy Rep; 2024 Dec; 3(1):. PubMed ID: 39006309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Bright Horizon of Intelligent Targeted-cancer Therapy: Nanoparticles Against Breast Cancer Stem Cells.
    Vaez A; Abbasi M; Shabani L; Azizipour E; Shafiee M; Zare MA; Rahbar O; Azari A; Amani AM; Golchin A
    Curr Stem Cell Res Ther; 2023; 18(6):787-799. PubMed ID: 36200213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
    Sun T; Yang W; Toprani SM; Guo W; He L; DeLeo AB; Ferrone S; Zhang G; Wang E; Lin Z; Hu P; Wang X
    Cell Commun Signal; 2020 Mar; 18(1):36. PubMed ID: 32138738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Theranostics for Breast Cancer Stem Cells.
    Moon WK; Kim HS
    Adv Exp Med Biol; 2021; 1187():267-281. PubMed ID: 33983583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.
    Das PK; Rakib MA; Khanam JA; Pillai S; Islam F
    Curr Stem Cell Res Ther; 2019; 14(8):669-682. PubMed ID: 31808385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of TAZ-Dependent Breast Cancer Vulnerabilities Using a Chemical Genomics Screening Approach.
    Shen H; Chen Y; Wan Y; Liu T; Wang J; Zhang Y; Wei L; Hu Q; Xu B; Chernov M; Frangou C; Zhang J
    Front Cell Dev Biol; 2021; 9():673374. PubMed ID: 34211974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
    Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
    J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cell technology in breast cancer: current status and potential applications.
    Chiotaki R; Polioudaki H; Theodoropoulos PA
    Stem Cells Cloning; 2016; 9():17-29. PubMed ID: 27217783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
    Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
    Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Breast Cancer Stem Cells Traits and Drug Resistance.
    Zheng Q; Zhang M; Zhou F; Zhang L; Meng X
    Front Pharmacol; 2020; 11():599965. PubMed ID: 33584277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs, a subpopulation of regulators, are involved in breast cancer progression through regulating breast cancer stem cells.
    Fan X; Chen W; Fu Z; Zeng L; Yin Y; Yuan H
    Oncol Lett; 2017 Nov; 14(5):5069-5076. PubMed ID: 29142594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-200c/141 Regulates Breast Cancer Stem Cell Heterogeneity via Targeting HIPK1/β-Catenin Axis.
    Liu B; Du R; Zhou L; Xu J; Chen S; Chen J; Yang X; Liu DX; Shao ZM; Zhang L; Yu Z; Xie N; Guan JL; Liu S
    Theranostics; 2018; 8(21):5801-5813. PubMed ID: 30613263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic, structural, and ultrastructural analysis of triple-negative breast cancer cell lines and breast cancer stem cell subpopulation.
    Moreira MP; Brayner FA; Alves LC; Cassali GD; Silva LM
    Eur Biophys J; 2019 Oct; 48(7):673-684. PubMed ID: 31485678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fate decisions of breast cancer stem cells in cancer progression.
    Xu H; Zhang F; Gao X; Zhou Q; Zhu L
    Front Oncol; 2022; 12():968306. PubMed ID: 36046046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
    Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
    Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells.
    Yousefnia S; Seyed Forootan F; Seyed Forootan S; Nasr Esfahani MH; Gure AO; Ghaedi K
    Front Oncol; 2020; 10():452. PubMed ID: 32426267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low concentrations of 5-aza-2'-deoxycytidine induce breast cancer stem cell differentiation by triggering tumor suppressor gene expression.
    Phan NL; Trinh NV; Pham PV
    Onco Targets Ther; 2016; 9():49-59. PubMed ID: 26730203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.